Pfizer publishes clinical trial diversity data from past decade, showing there's much work to be done
The pandemic turned a harsh spotlight on a historic lack of diversity in the biopharma industry. Now, in an effort to foster transparency, Pfizer has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
